Home>>Signaling Pathways>> Neuroscience>> Parkinson>>AUTEN-99

AUTEN-99 (Synonyms: Autophagy Enhancer-99)

Catalog No.GC46897

AUTEN-99 (hydrobromide) is a novel inhibitor of the myotubularin phosphatase Jumpy (also called MTMR14).

Products are for research use only. Not for human use. We do not sell to patients.

AUTEN-99 Chemical Structure

Cas No.: 1049780-58-6

Size Price Stock Qty
1 mg
$43.00
In stock
5 mg
$194.00
In stock
10 mg
$342.00
In stock
25 mg
$750.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

AUTEN-99 is an inhibitor of the phosphatase myotubularin-related protein 14 (MTMR14/Jumpy).1 It inhibits MTMR14/Jumpy activity in a cell-free assay when used at concentrations of 10 and 100 µM. AUTEN-99 (1 and 10 µM) enhances autophagic flux and increases the levels of LC3B-11 in HeLa cells. It increases survival of mouse primary neurons exposed to hydrogen peroxide as a model of oxidative stress when used at concentrations ranging from 0.5 to 5 µM. AUTEN-99 increases the number of autophagic structures in mouse pancreas, kidney, and liver following oral or intraperitoneal administration. It also induces autophagy in the Drosophila larval fat body and increases the percentage of flies climbing a glass column in a climbing assay in a transgenic model of Parkinson's disease.

1.KovÁcs, T., Billes, V., KomlÓs, M., et al.The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptomsSci. Rep.742014(2017)

Reviews

Review for AUTEN-99

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AUTEN-99

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.